Report Detail

Request for Sample of this report

Pharma & Healthcare 2018-2025 Axillary Hyperhidrosis Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

  • RnM1772721
    • |
  • 21 March, 2018
    • |
  • Global
    • |
  • 122 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Summary

This report studies the Axillary Hyperhidrosis Drug market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Axillary Hyperhidrosis Drug market by product type and application/end industries.

The global Axillary Hyperhidrosis Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Axillary Hyperhidrosis Drug.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Axillary Hyperhidrosis Drug in these regions, from 2013 to 2025 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America
Middle East and Africa

The major players in global and United States market, including
Allergan Plc
Brickell Biotech Inc
Dermira Inc
Dr. August Wolff GmbH & Co KG Arzneimittle
GlaxoSmithKline Plc
TheraVida Inc
On the basis of product, the market is primarily split into
Botulinum ToxinA
Glycopyrrolate
Glycopyrronium Tosylate
Others
On the basis on the end users/application, this report covers
Clinic
Hospital
Home Care


Table of Contents

    2018-2025 Axillary Hyperhidrosis Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

      1 Methodology and Data Source

      • 1.1 Methodology/Research Approach
        • 1.1.1 Research Programs/Design
        • 1.1.2 Market Size Estimation
        • 1.1.3 Market Breakdown and Data Triangulation
      • 1.2 Data Source
        • 1.2.1 Secondary Sources
        • 1.2.2 Primary Sources
      • 1.3 Disclaimer

      2 Axillary Hyperhidrosis Drug Market Overview

      • 2.1 Axillary Hyperhidrosis Drug Product Overview
      • 2.2 Axillary Hyperhidrosis Drug Market Segment by Type
        • 2.2.1 Botulinum ToxinA
        • 2.2.2 Glycopyrrolate
        • 2.2.3 Glycopyrronium Tosylate
        • 2.2.4 Others
      • 2.3 Global Axillary Hyperhidrosis Drug Product Segment by Type
        • 2.3.1 Global Axillary Hyperhidrosis Drug Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
        • 2.3.2 Global Axillary Hyperhidrosis Drug Sales (K Pcs) and Market Share (%) by Type (2013-2018)
        • 2.3.3 Global Axillary Hyperhidrosis Drug Revenue (Million USD) and Market Share (%) by Type (2013-2018)
        • 2.3.4 Global Axillary Hyperhidrosis Drug Price (USD/Pcs) by Type (2013-2018)
      • 2.4 United States Axillary Hyperhidrosis Drug Product Segment by Type
        • 2.4.1 United States Axillary Hyperhidrosis Drug Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
        • 2.4.2 United States Axillary Hyperhidrosis Drug Sales (K Pcs) and Market Share by Type (2013-2018)
        • 2.4.3 United States Axillary Hyperhidrosis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
        • 2.4.4 United States Axillary Hyperhidrosis Drug Price (USD/Pcs) by Type (2013-2018)

      3 Axillary Hyperhidrosis Drug Application/End Users

      • 3.1 Axillary Hyperhidrosis Drug Segment by Application/End Users
        • 3.1.1 Clinic
        • 3.1.2 Hospital
        • 3.1.3 Home Care
      • 3.2 Global Axillary Hyperhidrosis Drug Product Segment by Application
        • 3.2.1 Global Axillary Hyperhidrosis Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
        • 3.2.2 Global Axillary Hyperhidrosis Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)
      • 3.3 United States Axillary Hyperhidrosis Drug Product Segment by Application
        • 3.3.1 United States Axillary Hyperhidrosis Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
        • 3.3.2 United States Axillary Hyperhidrosis Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)

      4 Axillary Hyperhidrosis Drug Market Status and Outlook by Regions

      • 4.1 Global Market Status and Outlook by Regions
        • 4.1.1 Global Axillary Hyperhidrosis Drug Market Size and CAGR by Regions (2013, 2017 and 2025)
        • 4.1.2 North America
        • 4.1.3 Asia-Pacific
        • 4.1.4 Europe
        • 4.1.5 South America
        • 4.1.6 Middle East and Africa
        • 4.1.7 United States
      • 4.2 Global Axillary Hyperhidrosis Drug Sales and Revenue by Regions
        • 4.2.1 Global Axillary Hyperhidrosis Drug Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
        • 4.2.2 Global Axillary Hyperhidrosis Drug Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
        • 4.2.3 Global Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        • 4.2.4 North America Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        • 4.2.5 Europe Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        • 4.2.6 Asia-Pacific Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        • 4.2.7 South America Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
        • 4.2.8 Middle East and Africa Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        • 4.2.9 United States Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

      5 Global Axillary Hyperhidrosis Drug Market Competition by Players/Manufacturers

      • 5.1 Global Axillary Hyperhidrosis Drug Sales (K Pcs) and Market Share by Players (2013-2018)
      • 5.2 Global Axillary Hyperhidrosis Drug Revenue (Million USD) and Share by Players (2013-2018)
      • 5.3 Global Axillary Hyperhidrosis Drug Average Price (USD/Pcs) by Players (2013-2018)
      • 5.4 Global Top Players Axillary Hyperhidrosis Drug Manufacturing Base Distribution, Sales Area, Product Types
      • 5.5 Axillary Hyperhidrosis Drug Market Competitive Situation and Trends
        • 5.5.1 Axillary Hyperhidrosis Drug Market Concentration Rate
        • 5.5.2 Global Axillary Hyperhidrosis Drug Market Share (%) of Top 3 and Top 5 Players
        • 5.5.3 Mergers & Acquisitions, Expansion

      6 United States Axillary Hyperhidrosis Drug Market Competition by Players/Manufacturers

      • 6.1 United States Axillary Hyperhidrosis Drug Sales (K Pcs) and Market Share by Players (2013-2018)
      • 6.2 United States Axillary Hyperhidrosis Drug Revenue (Million USD) and Share by Players (2013-2018)
      • 6.3 United States Axillary Hyperhidrosis Drug Average Price (USD/Pcs) by Players (2013-2018)
      • 6.4 United States Axillary Hyperhidrosis Drug Market Share (%) of Top 3 and Top 5 Players

      7 Axillary Hyperhidrosis Drug Players/Manufacturers Profiles and Sales Data

      • 7.1 Allergan Plc
        • 7.1.1 Company Basic Information, Manufacturing Base and Competitors
        • 7.1.2 Axillary Hyperhidrosis Drug Product Category, Application and Specification
          • 7.1.2.1 Product A
          • 7.1.2.2 Product B
        • 7.1.3 Allergan Plc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        • 7.1.4 Main Business/Business Overview
      • 7.2 Brickell Biotech Inc
        • 7.2.1 Company Basic Information, Manufacturing Base and Competitors
        • 7.2.2 Axillary Hyperhidrosis Drug Product Category, Application and Specification
          • 7.2.2.1 Product A
          • 7.2.2.2 Product B
        • 7.2.3 Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        • 7.2.4 Main Business/Business Overview
      • 7.3 Dermira Inc
        • 7.3.1 Company Basic Information, Manufacturing Base and Competitors
        • 7.3.2 Axillary Hyperhidrosis Drug Product Category, Application and Specification
          • 7.3.2.1 Product A
          • 7.3.2.2 Product B
        • 7.3.3 Dermira Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        • 7.3.4 Main Business/Business Overview
      • 7.4 Dr. August Wolff GmbH & Co KG Arzneimittle
        • 7.4.1 Company Basic Information, Manufacturing Base and Competitors
        • 7.4.2 Axillary Hyperhidrosis Drug Product Category, Application and Specification
          • 7.4.2.1 Product A
          • 7.4.2.2 Product B
        • 7.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        • 7.4.4 Main Business/Business Overview
      • 7.5 GlaxoSmithKline Plc
        • 7.5.1 Company Basic Information, Manufacturing Base and Competitors
        • 7.5.2 Axillary Hyperhidrosis Drug Product Category, Application and Specification
          • 7.5.2.1 Product A
          • 7.5.2.2 Product B
        • 7.5.3 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        • 7.5.4 Main Business/Business Overview
      • 7.6 TheraVida Inc
        • 7.6.1 Company Basic Information, Manufacturing Base and Competitors
        • 7.6.2 Axillary Hyperhidrosis Drug Product Category, Application and Specification
          • 7.6.2.1 Product A
          • 7.6.2.2 Product B
        • 7.6.3 TheraVida Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
        • 7.6.4 Main Business/Business Overview

      8 Axillary Hyperhidrosis Drug Manufacturing Cost, Industrial Chain and Downstream Buyers

      • 8.1 Axillary Hyperhidrosis Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
        • 8.1.4 Market Concentration Rate of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
        • 8.2.1 Raw Materials
        • 8.2.2 Labor Cost
        • 8.2.3 Manufacturing Expenses
      • 8.3 Axillary Hyperhidrosis Drug Industrial Chain Analysis
      • 8.4 Downstream Buyers in United States

      9 Marketing Strategy Analysis, Distributors and Market Effect Factors

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
        • 9.1.3 Marketing Channel Development Trend
      • 9.2 Distributors in Untied States
      • 9.3 Market Effect Factors Analysis
        • 9.3.1 Economic/Political Environmental Change
        • 9.3.2 Downstream Demand Change
        • 9.3.3 Technology Progress in Related Industry
        • 9.3.4 Substitutes Threat

      10 Global Axillary Hyperhidrosis Drug Market Forecast

      • 10.1 Global Axillary Hyperhidrosis Drug Sales, Revenue Forecast (2018-2025)
        • 10.1.1 Global Axillary Hyperhidrosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
        • 10.1.2 Global Axillary Hyperhidrosis Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
      • 10.2 United States Axillary Hyperhidrosis Drug Market Forecast
        • 10.2.1 United States Axillary Hyperhidrosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
        • 10.2.2 United States Axillary Hyperhidrosis Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
      • 10.3 Global Axillary Hyperhidrosis Drug Forecast by Regions
        • 10.3.1 North America Axillary Hyperhidrosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        • 10.3.2 Europe Axillary Hyperhidrosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        • 10.3.3 Asia-Pacific Axillary Hyperhidrosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        • 10.3.4 South America Axillary Hyperhidrosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
        • 10.3.5 Middle East and Africa Axillary Hyperhidrosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
      • 10.4 Axillary Hyperhidrosis Drug Forecast by Type
        • 10.4.1 Global Axillary Hyperhidrosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
        • 10.4.2 United States Axillary Hyperhidrosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
      • 10.5 Axillary Hyperhidrosis Drug Forecast by Application
        • 10.5.1 Global Axillary Hyperhidrosis Drug Sales (K Pcs) Forecast by Application (2018-2025)
        • 10.5.2 United States Axillary Hyperhidrosis Drug Sales (K Pcs) Forecast by Application (2018-2025)

      11 Research Findings and Conclusion

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,600.00
      		$7,200.00
      		2,916.00
      		5,832.00
      		3,380.40
      		6,760.80
      		557,136.00
      		1,114,272.00
      		300,240.00
      		600,480.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo